Michael Amoroso - Oct 15, 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
President and CEO, Director
Signature
/s/ Dario Scimeca, Attorney-in-fact for Michael Amoroso
Stock symbol
DTIL
Transactions as of
Oct 15, 2022
Transactions value $
-$14,528
Form type
4
Date filed
10/18/2022, 04:13 PM
Previous filing
Sep 28, 2022
Next filing
Oct 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +24.2K 24.2K Oct 15, 2022 Direct F1, F2
transaction DTIL Common Stock Sale -$14.5K -11K -45.46% $1.32 13.2K Oct 17, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -24.2K -100% $0.00* 0 Oct 15, 2022 Common Stock 24.2K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting and settlement of Restricted Stock Units ("RSUs") on October 15, 2022.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022.